Extracellular vesicles as a modern biomarker of diabetic foot syndrome

The aims of the study are:

1. Improvement of the quality of diabetes patients care, in particular those who developed DFS. This will be achieved through selection of a biomarker enabling the use of EVs in the context of the estimation of risk of occurrence and course of DFS.
2. Development of a pattern for pre-selection of the group of patients most exposed to DFS.

This will enable increased supervision and implementation of preventive actions, which would have a key impact on the patients’ quality of life and their survival. As a consequence of those actions, it will be possible to reduce the risk of amputation among the patients, which will directly contribute to the improvement of their quality of life.

3. Improvement of the student’s soft skills – conducting prospective studies, molecular analysis of the obtained biological material, biostatistical analysis of the obtained results and start of cooperation with the private sector.
4. Promotion of Polish achievements on the international scene through the publication of the results in a journal with worldwide range from the list of the Ministry of Science and Education (MEiN).